The short answer
Annual low-dose CT cut lung cancer deaths by 20 percent in the National Lung Screening Trial. It also produces false positives and can find things outside the lungs.
The USPSTF recommends annual low-dose CT for adults 50 to 80 who have a 20 pack-year smoking history and currently smoke or quit within the past 15 years. It is a Grade B recommendation.
In the National Lung Screening Trial, annual low-dose CT reduced lung cancer deaths by about 20 percent compared with chest X-ray.
Lung-RADS categories 1 and 2 both mean the next scan is in 12 months.
NCI notes that using Lung-RADS gives somewhat lower false-positive rates than the original NLST definition.
On this page
Choose how you want to read this
The whole article, with every detail and caution.
This page is for people weighing lung cancer screening, and for anyone whose CT scan found a lung nodule. It covers who qualifies, what the scan finds, and how to tell which follow-up rules apply to you.
Who lung screening is recommended for
The USPSTF recommends annual low-dose CT for adults aged 50 to 80 who have at least a 20 pack-year smoking history. The recommendation covers people who either still smoke or quit within the past 15 years. It carries a Grade B. That means the Task Force found moderate net benefit and recommends offering it.
A pack-year is one pack a day for one year. Half a pack a day for 40 years counts the same as two packs a day for 10. Work out your own total before the appointment. Eligibility and insurance coverage both turn on that number.
The recommendation also says when to stop. That is once you have not smoked for 15 years, or once a health problem would prevent you from tolerating curative lung surgery. Screening only helps if a found cancer can be treated.
What the evidence shows
The National Lung Screening Trial found a 20 percent reduction in lung cancer deaths with annual low-dose CT compared with chest X-ray. The European NELSON trial pointed the same way. After at least 10 years of follow-up, NCI reports a lung cancer mortality rate ratio of 0.76 in screened men compared with usual care.
Overdiagnosis is the harm people most want a number for. NCI does not give one. It says some cancers found by screening do appear to be overdiagnosed. But it says published estimates vary a lot, so the true size is not clear.
Reading a screening result
Many scans show small spots in the lungs. Most are not cancer, but some need a repeat scan or more tests.
The Lung-RADS system gives each scan a category. Categories 1 and 2 both mean annual screening continues, with the next scan in 12 months. Category 3 is "probably benign" and brings a 6-month repeat scan. Category 4A moves to a 3-month scan, and 4B or 4X to further imaging or tissue sampling.
Lung-RADS also changed what gets called positive at all. NCI says that using Lung-RADS gives somewhat lower false-positive rates than the definition used in the National Lung Screening Trial. A false positive can still mean extra scans or tests, so it helps to know that going in.
Two rulebooks, and knowing which one applies
Reports can use different systems, and that can be confusing.
If a nodule is found on a lung cancer screening CT, the report uses Lung-RADS categories.
If a nodule is found incidentally, it was seen on a CT ordered for another reason, such as chest pain, an injury, or before surgery. Radiologists often follow different guidelines for those nodules, and the follow-up plan can differ from Lung-RADS. We have not confirmed the details of those guidelines in NCI or CDC sources, so this page does not list them.
If you are trying to make sense of a report, the first question is which system was used. A category number means Lung-RADS. Ask your doctor to explain any other plan, and why it was chosen.
The costs of screening, stated plainly
Screening has real benefits, and it also has downsides. Here are the main ones.
Findings outside the lungs. The scan also shows nearby structures, so it can find things that are not in the lungs. Lung-RADS flags significant ones with an S modifier. Some of these findings lead to more tests that end in nothing.
Radiation. The dose per scan is small. NCI reports a mean effective dose of 1.4 mSv for low-dose CT in the National Lung Screening Trial. It estimates that participants received about 8 mSv over three years of screening once follow-up imaging is counted. The dose adds up across years of annual scans. NCI says the benefits outweigh the radiation risk for people at high risk, and the USPSTF limits screening to appropriate candidates.
Procedures. NCI says false positives can lead to unnecessary invasive procedures, and tests after a scan can cause complications.
Making screening work
Screening is a program, not an event. The USPSTF recommends annual scans, and any follow-up scan needs to be booked on time. A common problem is a 6-month or 3-month recommendation that quietly never gets booked.
Before you leave, write down the category, the exact next date, and who is responsible for reminding you. Quitting smoking lowers lung cancer risk, so ask for help at the same visit.
Sources

Common questions
I do not meet the pack-year threshold but I am worried. Can I still get screened?
The benefit-to-harm balance behind the recommendation was measured in people who meet the eligibility criteria, and it does not automatically carry over to lower-risk groups, where the same false positives and incidental findings occur while fewer cancers are found. Ask your doctor and your insurer how coverage works for you. If you have other exposures or a strong family history, mention them. They can change the conversation, even though they are not part of the USPSTF criteria.
What is a pack-year and how do I calculate mine?
One pack-year is smoking one pack a day for one year. Multiply packs per day by years smoked. Half a pack a day for 40 years is 20 pack-years, and two packs a day for 10 years is also 20. Add up separate periods if your smoking changed over time. Bring the number to the appointment, since eligibility hinges on it.
If I quit smoking 20 years ago, why am I no longer eligible?
The USPSTF recommends screening only for people who currently smoke or quit within the past 15 years. It advises stopping once someone has not smoked for 15 years, or has health problems that substantially limit life expectancy or the ability to have curative lung surgery. Ask your doctor what applies to you.
The report mentioned something not in my lungs. What happens now?
A chest CT also shows nearby structures, so it can pick up things that are not in the lungs. On a Lung-RADS report, the S modifier marks a clinically significant finding that is not lung cancer. Ask specifically whether the finding needs action, watching, or nothing. If your doctor says it needs follow-up, book it.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Talk with a trained specialist or navigator
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Fever of 100.4°F (38°C) or higher during chemo, severe pain, or trouble breathing: call your cancer care team right away, day or night. Call 911 for an emergency.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Written by: Cancer ExplainedSources last checked: 2026-08-13 what this meansLast updated: 2026-10-02Next planned review: 2027-01-30
Review details and limits
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and then compared with the sources listed on it, looking for statements those sources do not back up. That check is not a sentence-by-sentence record and can miss errors. It is not a medical review, and it does not confirm the page is complete or right for your situation.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Words to know
Tap any term to see what it means.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and then compared with the sources listed on it, looking for statements those sources do not back up. That check is not a sentence-by-sentence record and can miss errors. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
- A Symptom Is Not a Diagnosis
- What Symptoms Should I Call My Oncology Team About Today?
- Cancer-Prevention Claims: Evidence, Uncertainty, or Myth?
- PSA Screening Benefits, Harms, and Shared Decisions
- Cancer Screening Schedule After a Previous Cancer
- Screening When a Relative Was Diagnosed Young
- What Cancer Screening Can and Cannot Detect
- What Does Lung-RADS Mean on a Lung Screening CT?
